IRCT20200115046143N3 IRCT 2025-10-18 Hamedan University of Medical Sciences Preparation and Clinical evaluation of the combined solution of minoxidil, azelaic acid and spironolactone in the treatment of androgenic alopecia Preparation and Clinical evaluation of the combined solution of minoxidil, azelaic acid and spironolactone in the treatment of androgenic alopecia 2025-10-22 anticipated 50 Complete https://irct.ir/trial/86786 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random assignment of the patients to the intervention and control groups through the drawing of lots. To do this, we prepare two sheets and write "intervention" on one sheet and "control" on another. Then, by referring each patient, one of the sheets will be randomly taken and the patient will be assigned to the intervention or control group, Blinding description: The shape of the medications will be perfectly the same in the two groups. Therefore, patients will be unaware of the type of intervention. The physician who will examine the patients will not be aware of the intervention. Therefore, the trial will be run as double-blind. 3 Androgenic Alopecia. Intervention 1: Intervention group: They will receive a solution containing minoxidil 5%, spironolactone 5%, and azelaic acid 1.5% twice daily for three months. Intervention 2: Control group: The patients use a solution containing minoxidil 5% in two sessions for three months. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Patient satisfaction is a prerequisite for data dissemination